Article
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2023
Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, Escremim de Paula Flávia, Berardinelli Gustavo Noriz, Sant'Anna Débora, Santana Iara, da Silva Vinicius Duval, Da Silva Eduardo Caetano Albino, Miziara José Elias, Mourão Dias Josiane, Antoniazzi Augusto, Jacinto Alexandre, De Marchi Pedro, Molina-Vila Miguel Angel, Ferro Leal Leticia, Reis Rui Manuel
Abstract excerpt
INTRODUCTION: TP53 is the most frequently mutated gene in lung tumors, but its prognostic role in admixed populations, such as Brazilians, remains unclear. In this study, we aimed to evaluate the frequency and clinicopathological impact of TP53 mutations in non-small cell lung cancer (NSCLC) patients in Brazil. METHODS: We analyzed 446 NSCLC patients from Barretos Cancer Hospital. TP53 mutational status was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
